Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaxi Yang

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Angewandte Chemie (International Ed. in English)|August 27, 2015
Redox-neutral rhodium-catalyzed C-H functionalization of arylamine N-oxides with diazo compounds: primary C(sp(3))-H/C(sp(2))-H activation and oxygen-atom transferBing Zhou, Zhaoqiang Chen, Yaxi Yang, et al.
Journal of Medicinal Chemistry|February 17, 2023
Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic SteatohepatitisLiuyu Hu, Yipei Gu, Ju Liang, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2025
The Predictive Value of Insulin Resistance Surrogates for Diabetic Kidney Disease in Type 2 Diabetes MellitusQiuying Sun, Meiru Zhao, Xiaonan Wang, et al.
Journal of Medicinal Chemistry|July 23, 2024
Discovery of Potent and Selective G9a Degraders for the Treatment of Pancreatic CancerYunkai Shi, Qianqian Shen, Ruikai Long, et al.
Biomaterials Research|July 16, 2024
Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver SystemKe Wang, Yuankui Zhu, Mengqing Li, et al.
Journal of Medicinal Chemistry|March 27, 2020
Discovery of 8-Methyl-pyrrolo[1,2-<i>a</i>]pyrazin-1(2<i>H</i>)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorsZizhou Li, Senhao Xiao, Yaxi Yang, et al.
European Journal of Medicinal Chemistry|June 7, 2022
Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administrationJing Niu, Hudagula Bai, Zizhou Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2023
Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibodyHuixia He, Feifei Lei, Le Huang, et al.
Research in Developmental Disabilities|November 17, 2024
Cognitively combined/engaged physical activity for the executive function, symptomology, and motor competence of children and adolescents with attention-deficit/hyperactivity disorder: A systematic review and meta-analysisYuan Fang, Fenghua Sun, Zixin Wang, et al.
European Journal of Medicinal Chemistry|December 25, 2022
Cyclization strategy leads to highly potent Bromodomain and extra-terminal (BET) Bromodomain inhibitors for the treatment of acute liver injuryChao Chen, Tian Lu, Panyu Chen, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Angewandte Chemie (International Ed. in English)|August 27, 2015
Redox-neutral rhodium-catalyzed C-H functionalization of arylamine N-oxides with diazo compounds: primary C(sp(3))-H/C(sp(2))-H activation and oxygen-atom transferBing Zhou, Zhaoqiang Chen, Yaxi Yang, et al.
Journal of Medicinal Chemistry|February 17, 2023
Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic SteatohepatitisLiuyu Hu, Yipei Gu, Ju Liang, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 15, 2025
The Predictive Value of Insulin Resistance Surrogates for Diabetic Kidney Disease in Type 2 Diabetes MellitusQiuying Sun, Meiru Zhao, Xiaonan Wang, et al.
Journal of Medicinal Chemistry|July 23, 2024
Discovery of Potent and Selective G9a Degraders for the Treatment of Pancreatic CancerYunkai Shi, Qianqian Shen, Ruikai Long, et al.
Biomaterials Research|July 16, 2024
Genetically Modified Hepatocytes Targeting Bilirubin and Ammonia Metabolism for the Construction of Bioartificial Liver SystemKe Wang, Yuankui Zhu, Mengqing Li, et al.
Journal of Medicinal Chemistry|March 27, 2020
Discovery of 8-Methyl-pyrrolo[1,2-<i>a</i>]pyrazin-1(2<i>H</i>)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorsZizhou Li, Senhao Xiao, Yaxi Yang, et al.
European Journal of Medicinal Chemistry|June 7, 2022
Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administrationJing Niu, Hudagula Bai, Zizhou Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 1, 2023
Immunotherapy of Epstein-Barr virus (EBV) infection and EBV-associated hematological diseases with gp350/CD89-targeted bispecific antibodyHuixia He, Feifei Lei, Le Huang, et al.
Research in Developmental Disabilities|November 17, 2024
Cognitively combined/engaged physical activity for the executive function, symptomology, and motor competence of children and adolescents with attention-deficit/hyperactivity disorder: A systematic review and meta-analysisYuan Fang, Fenghua Sun, Zixin Wang, et al.
European Journal of Medicinal Chemistry|December 25, 2022
Cyclization strategy leads to highly potent Bromodomain and extra-terminal (BET) Bromodomain inhibitors for the treatment of acute liver injuryChao Chen, Tian Lu, Panyu Chen, et al.
Pageof 7